0.9786
price down icon3.11%   -0.0314
after-market After Hours: 1.00 0.0214 +2.19%
loading
Lucid Diagnostics Inc stock is traded at $0.9786, with a volume of 1.09M. It is down -3.11% in the last 24 hours and down -14.90% over the past month. Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
See More
Previous Close:
$1.01
Open:
$1.02
24h Volume:
1.09M
Relative Volume:
0.92
Market Cap:
$105.88M
Revenue:
$4.35M
Net Income/Loss:
$-45.53M
P/E Ratio:
-0.9061
EPS:
-1.08
Net Cash Flow:
$-44.79M
1W Performance:
-11.04%
1M Performance:
-14.90%
6M Performance:
+2.16%
1Y Performance:
+22.71%
1-Day Range:
Value
$0.9715
$1.0283
1-Week Range:
Value
$0.9715
$1.17
52-Week Range:
Value
$0.7201
$1.80

Lucid Diagnostics Inc Stock (LUCD) Company Profile

Name
Name
Lucid Diagnostics Inc
Name
Phone
212 949 4319
Name
Address
360 MADISON AVENUE, NEW YORK
Name
Employee
70
Name
Twitter
Name
Next Earnings Date
2025-03-24
Name
Latest SEC Filings
Name
LUCD's Discussions on Twitter

Compare LUCD with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
LUCD
Lucid Diagnostics Inc
0.9786 109.28M 4.35M -45.53M -44.79M -1.08
Medical Devices icon
ABT
Abbott Laboratories
126.19 223.66B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
104.92 157.95B 18.49B 2.51B 2.72B 1.68
Medical Devices icon
SYK
Stryker Corp
392.73 153.02B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
90.24 117.42B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
79.31 47.61B 5.69B 4.15B 623.10M 6.95

Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-27-21 Initiated Ascendiant Capital Markets Buy
Nov-08-21 Initiated BTIG Research Buy
Nov-08-21 Initiated Cantor Fitzgerald Overweight
Nov-08-21 Initiated Needham Buy

Lucid Diagnostics Inc Stock (LUCD) Latest News

pulisher
Jul 31, 2025

PAVmed gets 180-day extension to regain Nasdaq listing compliance - MSN

Jul 31, 2025
pulisher
Jul 31, 2025

PAVmed CEO and CFO to Present Q2 2025 Results and Growth Strategy Update on August 14 - Stock Titan

Jul 31, 2025
pulisher
Jul 30, 2025

Cancer Prevention Leader Lucid Diagnostics to Reveal Q2 2025 Financial Results and Growth Strategy - Stock Titan

Jul 30, 2025
pulisher
Jul 30, 2025

Lucid nearing Medicare coverage for EsoGuard test, maintain at Buy: BTIG - MSN

Jul 30, 2025
pulisher
Jul 29, 2025

What explains LUCD's volatile earnings in 2024? - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

Why did LUCD's Q4 earnings fall short of forecasts? - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

What institutional investors are buying Lucid Diagnostics Inc. stockPre Market Forecasts Backed By Experts - jammulinksnews.com

Jul 29, 2025
pulisher
Jul 28, 2025

How does Lucid Diagnostics Inc. compare to its industry peersStock Strategy Picks For 2025 - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Lucid Diagnostics' Medicare Coverage Catalyst: A Strategic Inflection Point for Esophageal Cancer Prevention - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

How many analysts rate Lucid Diagnostics Inc. as a “Buy”Achieve consistent profits with expert strategies - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How does Lucid Diagnostics Inc. generate profit in a changing economyAchieve consistent profits with smart trading - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

When is Lucid Diagnostics Inc. stock expected to show significant growthGame-changing capital returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What is Lucid Diagnostics Inc. company’s growth strategyAchieve consistent profits with proven methods - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Lucid Diagnostics Inc. a growth stock or a value stockInvest confidently with professional market insights - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for Lucid Diagnostics Inc.Extraordinary market timing - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Lucid Diagnostics Inc. Earnings Report Breakdown: What Investors Should KnowFree Stock Market Insider Analysis - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

What is the dividend policy of Lucid Diagnostics Inc. stockDiscover the next big stock winners - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Sectors Driving Future Growth for Lucid Diagnostics Inc. StockDaily Price Surge List - Newser

Jul 27, 2025
pulisher
Jul 26, 2025

Why Lucid Diagnostics Inc. stock attracts strong analyst attentionDaily Volume Leaders - metal.it

Jul 26, 2025
pulisher
Jul 25, 2025

What drives Lucid Diagnostics Inc. stock priceHigh-yield growth strategies - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

What analysts say about Lucid Diagnostics Inc. stockFree Consultation - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 23, 2025

Is Lucid Diagnostics Inc. a good long term investmentStrong return on assets - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Lucid Diagnostics Inc. Stock Analysis and ForecastBreakthrough capital growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 21, 2025

Immunovia's Strategic Hiring of Natalie Carfora: A Catalyst for Reimbursement Success and Market Expansion of PancreaSure - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Immunovia Names Natalie Carfora VP of Market Access and Reimbursement Ahead of PancreaSure Launch - AInvest

Jul 21, 2025
pulisher
Jul 20, 2025

[New] Lucid Stock Price Prediction 2024, 2025 To 2050 - Exla Resources

Jul 20, 2025
pulisher
Jul 17, 2025

Lucid says meeting scheduled to determine Medicare coverage for cancer test - MSN

Jul 17, 2025
pulisher
Jul 17, 2025

LUCD’s 2025 Market Dance: Up 26.00% – Time to Invest? - investchronicle.com

Jul 17, 2025
pulisher
Jul 16, 2025

what makes lucid diagnostics inc. stock price move sharply3x Growth Potential - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

Esophageal Cancer Detection Revolution: Lucid's Medicare Milestone and Its Market Impact - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Lucid says AdCom meeting set to determine cancer test coverage - Seeking Alpha

Jul 16, 2025
pulisher
Jul 16, 2025

Lucid Diagnostics Inc. shares fall 5.98% intraday as MolDX convenes expert medical panel on Medicare. - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test - StreetInsider

Jul 16, 2025
pulisher
Jul 15, 2025

How Lucid Diagnostics Inc. stock performs during market volatilityRisk Managed Trading Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Lucid Diagnostics Inc. stock price move sharplyInvestor Favorite Picks - Newser

Jul 15, 2025

Lucid Diagnostics Inc Stock (LUCD) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$288.40
price down icon 3.31%
medical_devices STE
$226.49
price down icon 1.21%
medical_devices PHG
$26.20
price down icon 2.28%
$80.77
price down icon 9.31%
$71.32
price down icon 0.45%
medical_devices EW
$79.31
price down icon 2.28%
Cap:     |  Volume (24h):